Literature DB >> 9725221

The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor kappa B.

S J Gobin1, V Keijsers, M van Zutphen, P J van den Elsen.   

Abstract

HLA class I expression is tightly controlled at the transcriptional level by several conserved regulatory elements in the proximal promoter region. In this study, the two putative kappa B motifs of enhancer A (kappa B1 and kappa B2) of the classical and nonclassical HLA class I genes were investigated for their binding properties of transcription factors and tested for their contribution to the NF-kappa B-induced route of transactivation. It was shown that NF-kappa B-induced transactivation through enhancer A is most important for the HLA-A locus, which contains two NF-kappa B binding sites. Although the enhancer A of HLA-B contains only one NF-kappa B binding site (kappa B1), there was still a moderate transactivation by NF-kappa B. Since HLA-F, which also possesses one NF-kappa B binding site but lacks protein binding to its KB2 site, was not transactivated by NF-kappa B, the NF-kappa B-mediated transactivation through the kappa B1 motif in HLA-B is most probably facilitated by binding of the transcription factor Spl to the upstream kappa B2 site. Thus, transcriptional regulation of HLA class I genes by NF-kappa B is restricted to the HLA-A and HLA-B loci.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725221

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  HLA-A and HLA-B transcription decrease with ageing in peripheral blood leucocytes.

Authors:  C Le Morvan; M Cogné; M Drouet
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

2.  Balancing immunity and tolerance: genetic footprint of natural selection in the transcriptional regulatory region of HLA-G.

Authors:  L Gineau; P Luisi; E C Castelli; J Milet; D Courtin; N Cagnin; B Patillon; H Laayouni; P Moreau; E A Donadi; A Garcia; A Sabbagh
Journal:  Genes Immun       Date:  2014-11-13       Impact factor: 2.676

3.  Computationally identifying novel NF-kappa B-regulated immune genes in the human genome.

Authors:  Rongxiang Liu; Richard C McEachin; David J States
Journal:  Genome Res       Date:  2003-03-12       Impact factor: 9.043

Review 4.  Expression of nonclassical MHC class Ib genes: comparison of regulatory elements.

Authors:  T Kevin Howcroft; Dinah S Singer
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

5.  Analysis of part of the chicken Rfp-Y region reveals two novel lectin genes, the first complete genomic sequence of a class I alpha-chain gene, a truncated class II beta-chain gene, and a large CR1 repeat.

Authors:  Sally Rogers; Iain Shaw; Norman Ross; Venugopal Nair; Lisa Rothwell; Jim Kaufman; Pete Kaiser
Journal:  Immunogenetics       Date:  2003-04-12       Impact factor: 2.846

6.  HLA-E, HLA-F, and HLA-G polymorphism: genomic sequence defines haplotype structure and variation spanning the nonclassical class I genes.

Authors:  Chul-Woo Pyo; Luke M Williams; Yuki Moore; Hironobu Hyodo; Shuying Sue Li; Lue Ping Zhao; Noriko Sageshima; Akiko Ishitani; Daniel E Geraghty
Journal:  Immunogenetics       Date:  2006-03-29       Impact factor: 2.846

Review 7.  NLRC5/CITA: A Key Player in Cancer Immune Surveillance.

Authors:  Sayuri Yoshihama; Saptha Vijayan; Tabasum Sidiq; Koichi S Kobayashi
Journal:  Trends Cancer       Date:  2017-01-10

8.  Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for HLA Class I Genes.

Authors:  Veron Ramsuran; Pedro G Hernández-Sanchez; Colm O'hUigin; Gaurav Sharma; Niamh Spence; Danillo G Augusto; Xiaojiang Gao; Christian A García-Sepúlveda; Gurvinder Kaur; Narinder K Mehra; Mary Carrington
Journal:  J Immunol       Date:  2017-02-01       Impact factor: 5.422

9.  The chicken BF1 (classical MHC class I) gene shows evidence of selection for diversity in expression and in promoter and signal peptide regions.

Authors:  Ann Marie O'Neill; Emily J Livant; Sandra J Ewald
Journal:  Immunogenetics       Date:  2009-02-11       Impact factor: 2.846

Review 10.  Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.

Authors:  Saptha Vijayan; Tabasum Sidiq; Suhail Yousuf; Peter J van den Elsen; Koichi S Kobayashi
Journal:  Immunogenetics       Date:  2019-01-31       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.